Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.
Open Access
- 15 July 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (2) , 457-463
- https://doi.org/10.4049/jimmunol.141.2.457
Abstract
We sought biochemical evidence for a role of C receptors types 1 (CR1) and 2 (CR2) in B cell activation. A flow cytometer was used to measure the fluorescence of tonsillar cells that had been loaded with the calcium-dependent indicator indo-1, and cells were stimulated by cross-linking cell-bound DA4.4 anti-IgM, Yz-1 anti-CR1 or HB5 anti-CR2 with goat anti-mouse IgG. There was a direct dose-response relationship between the proportion of cells having increased cytoplasmic free calcium concentration (Cai) after addition of second antibody and the amount of cell-bound Fab' DA4.4. In contrast, no rise in Cai was observed after cross-linking bound Yz-1 or HB5. To determine whether CR1 or CR2 could modify the increase in Cai induced by cross-linking membrane IgM, Cai was monitored after addition of second antibody to cells bearing combinations of either Yz-1 or HB5 with a limited amount of DA4.4. The combination of Yz-1 with DA4.4 yielded little or no further increase in the percentage of cells responding to cross-linking with elevated Cai compared with DA4.4 alone. However, the combination of HB5 with limited DA4.4 synergistically enhanced this response, resulting in stimulation that was equivalent to that obtained with optimal concentrations of DA4.4. The synergistic effect of CR2 was also observed with avidin as the cross-linking reagent for bound biotinylated HB5 and DA4.4, occurred in the presence of EGTA, and did not require T cells. Studies of the proliferation of B cell-enriched PBMC demonstrated that, whereas HB5 coupled to Sepharose alone induced little or no DNA synthesis, the combination of HB5 with limited DA4.4 on Sepharose induced a dose-related synergistic increase in the incorporation of [3H]thymidine.This publication has 52 references indexed in Scilit:
- Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.The Journal of Experimental Medicine, 1982
- Lack of binding of human C3, in its native state, to C3b receptors.The Journal of Immunology, 1981
- Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.The Journal of Immunology, 1981
- Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells.The Journal of Immunology, 1981
- Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.The Journal of Immunology, 1981
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- Crosslinking by ligands to surface immunoglobulin triggers mobilization of intracellular 45Ca2+ in B lymphocytes.The Journal of cell biology, 1979
- Receptors for C3 on Rat Peritoneal Mast CellsThe Journal of Immunology, 1977
- The Glomerular Complement Receptor in Immunologically Mediated Renal Glomerular InjuryNew England Journal of Medicine, 1976
- SURFACE MARKERS OF HUMAN EOSINOPHILS1976